Clinical trial

Sorafenib in Resected Non-small Cell Lung Carcinoma

NCT00532025

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-09-01

PhasePHASE2

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2009-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

SorafenibDRUG · verified · RxNorm: sorafenib

Sponsors & collaborators

Johannes Gutenberg University Mainzlead sponsor

Mapped research locations

MainzGermany2 EssenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00532025 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.